NASDAQ:QTRX Quanterix (QTRX) Stock Price, News & Analysis $3.28 +0.07 (+2.18%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$3.28 0.00 (0.00%) As of 10/9/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Quanterix Stock (NASDAQ:QTRX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Quanterix alerts:Sign Up Key Stats Today's Range$3.20▼$3.4550-Day Range$2.42▼$4.0352-Week Range$2.15▼$8.77Volume282,599 shsAverage Volume976,533 shsMarket Capitalization$155.11 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingReduce Company Overview Quanterix Corporation (NASDAQ:QTRX) is a life sciences company that develops technologies for detecting and measuring very low concentrations of biomarkers in blood and other biological samples. Its platform is designed to support research and clinical development in areas including neurology, oncology, immunology, infectious diseases and cardiovascular disease. The company’s core technology, Simoa (Single Molecule Array), uses digital immunoassay methods to detect proteins and other biomarkers at levels below the practical range of many conventional laboratory tests. Quanterix offers laboratory instruments such as the HD-X, SR-X and SP-X systems, along with assay kits, consumables, software and related laboratory services. Its products are used by pharmaceutical and biotechnology companies, academic and government researchers, diagnostic developers and clinical laboratories. Founded in 2007 and headquartered in Billerica, Massachusetts, Quanterix serves customers through direct and commercial channels in the United States and internationally. The company has also expanded its offerings through partnerships and acquisitions, including the addition of technologies intended to broaden its biomarker analysis capabilities. Masoud Toloue has served as Quanterix’s president and chief executive officer since January 2024.AI Generated. May Contain Errors. Read More Quanterix Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScoreQTRX MarketRank™: Quanterix scored higher than 24% of companies evaluated by MarketBeat, and ranked 809th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingReduce Consensus RatingQuanterix has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Downside RiskQuanterix has a consensus price target of $3.00, representing about 8.5% downside from its current price of $3.28.Amount of Analyst CoverageQuanterix has only been the subject of 3 research reports in the past 90 days.Read more about Quanterix's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Quanterix is -1.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Quanterix is -1.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuanterix has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Quanterix's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.83% of the float of Quanterix has been sold short.Short Interest Ratio / Days to CoverQuanterix has a short interest ratio ("days to cover") of 7.43.Change versus previous monthShort interest in Quanterix has recently increased by 1.41%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldQuanterix does not currently pay a dividend.Dividend GrowthQuanterix does not have a long track record of dividend growth. News and Social Media4.3 / 5News Sentiment0.86 News SentimentQuanterix has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Quanterix this week, compared to 2 articles on an average week.Search Interest1 people have searched for QTRX on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Quanterix to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Quanterix insiders have not sold or bought any company stock.Percentage Held by Insiders1.50% of the stock of Quanterix is held by insiders.Percentage Held by Institutions86.48% of the stock of Quanterix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quanterix's insider trading history. Receive QTRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QTRX Stock News HeadlinesALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchOctober 8 at 6:33 PM | marketscreener.comMQuanterix and Innovita Expand IVD Access in China with National Medical Products Administration ApprovalsOctober 7 at 9:28 AM | finance.yahoo.comYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer. | Profits Run (Ad)Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026September 25, 2026 | markets.ft.comQuanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel DevelopmentSeptember 25, 2026 | marketscreener.comMQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 16, 2026 | businesswire.comQuanterix average analyst price target decreased by 18.18% to $3.06September 15, 2026 | msn.comQuanterix Names Yuri Fesko Chief Medical OfficerSeptember 14, 2026 | rttnews.comSee More Headlines QTRX Stock Analysis - Frequently Asked Questions How have QTRX shares performed this year? Quanterix's stock was trading at $6.36 at the beginning of the year. Since then, QTRX stock has decreased by 48.4% and is now trading at $3.28. How were Quanterix's earnings last quarter? Quanterix Corporation (NASDAQ:QTRX) released its quarterly earnings data on Monday, August, 10th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by $0.63. The company earned $32.91 million during the quarter, compared to analysts' expectations of $37.48 million. Quanterix had a negative trailing twelve-month return on equity of 26.09% and a negative net margin of 80.25%. Read the conference call transcript. When did Quanterix IPO? Quanterix (QTRX) raised $64 million in an IPO on Thursday, December 7th 2017. The company issued 4,275,200 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers. How do I buy shares of Quanterix? Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Quanterix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quanterix investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings8/10/2026Today10/09/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, QTRX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:QTRX CIK1503274 Webwww.quanterix.com Phone(617) 301-9400FaxN/AEmployees450Year Founded2007Price Target and Rating Average Price Target for Quanterix$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside-8.5%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($2.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$107.15 million Net Margins-80.25% Pretax Margin-81.68% Return on Equity-26.09% Return on Assets-19.03% Debt Debt-to-Equity RatioN/A Current Ratio3.40 Quick Ratio2.45 Sales & Book Value Annual Sales$138.90 million Price / Sales1.12 Cash FlowN/A Price / Cash FlowN/A Book Value$6.33 per share Price / Book0.52Miscellaneous Outstanding Shares47,290,000Free Float46,584,000Market Cap$155.11 million OptionableOptionable Beta1.02 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:QTRX) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredLook at Elon’s face after meeting with ChinaElon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Ex...International Living | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
